~~<i id='18DB63625A'><strike id='18DB63625A'><tt id='18DB63625A'><pre id='18DB63625A'></pre></tt></strike></i>~~

Home» comprehensive» fashion

fashion

author：knowledge 2025-09-30 15:45:54 Page View：7

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala
Next article： Cancer drug shortages should be causing more outrage

explore

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

NFL doctors' conflicts of interest could endanger players, report says

CharlesRexArbogast/APDoctorsthatworkforprofessionalfootballteamshaveconflictsofinterestthatcouldjeop

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Google's generative AI to analyze medical images — and talk to docs

NOAHSEELAM/AFPviaGettyImagesGoogle’sgenerativeAIsystemproveditcananswermedicalexamquestions.Butnowth